All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled study

Journal of Hepatology

Volumn 58, Issue 1, 2013, Pages 31-37

  Kielland, Knut Boe ^a   Skaug, Kjell ^b   Amundsen, Ellen J ^c   Dalgard, Olav ^d  

^a INNLANDET HOSPITAL TRUST   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c NORWEGIAN INSTITUTE FOR ALCOHOL AND DRUG RESEARCH   (Norway)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cohort; Drug abuse; Hepatitis B; Liver disease; Overdose

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ACCIDENT; ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DEATH; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTOXICATION; INTRAVENOUS DRUG ABUSE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SUICIDE;

ACCIDENTS; ADULT; CARCINOMA, HEPATOCELLULAR; DRUG OVERDOSE; FEMALE; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE-RELATED DISORDERS; SUICIDE; YOUNG ADULT;

EID: 84871210488     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.08.024     Document Type: Article

References (33)

1. J.I. Esteban, S. Sauleda, and J. Quer The changing epidemiology of hepatitis C virus infection in Europe J Hepatol 48 2008 148 162
2. O. Dalgard, S. Jeansson, K. Skaug, N. Raknerud, and H. Bell Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum Scand J Gastroenterol 38 2003 864 870
3. M. Backmund, J. Reimer, K. Meyer, J.T. Gerlach, and R. Zachoval Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment Clin Infect Dis 40 2005 S330 S335
4. A. Alberti, L. Chemello, and L. Benvegnu Natural history of hepatitis C J Hepatol 31 1999 17 24
5. H.J. Alter, and L.B. Seeff Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome Semin Liver Dis 20 2000 17 35
6. L.B. Seeff Natural history of chronic hepatitis C Hepatology 36 2002 S35 S46
7. J.A. Salomon, M.C. Weinstein, J.K. Hammitt, and S.J. Goldie Empirically calibrated model of hepatitis C virus infection in the United States Am J Epidemiol 156 2002 761 773
8. A.J. Rodger, S. Roberts, A. Lanigan, S. Bowden, T. Brown, and N. Crofts Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975 Hepatology 32 2000 582 587
9. A.J. Freeman, M.G. Law, J.M. Kaldor, and G.J. Dore Predicting progression to cirrhosis in chronic hepatitis C virus infection J Viral Hepat 10 2003 285 293
10. J.L. Dienstag, M.G. Ghany, T.R. Morgan, A.M. Di Bisceglie, H.L. Bonkovsky, and H.Y. Kim A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C (HEP-10-2210) Hepatology 54 2011 396 405
11. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 1997 825 832
12. J. Grebely, J.D. Raffa, C. Lai, M. Krajden, T. Kerr, and B. Fischer Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents J Viral Hepat 16 2009 352 358
13. K.B. Kielland, and J.C. Siebke Hepatitis A-, B- and C-markers among Norwegian drug addicts in the period 1975-89 Tidsskr Nor Laegeforen 111 1991 821 824
14. J.A. Garson, C.J. Ring, and P.W. Tuke Improvement of HCV genome detection with "short" PCR products Lancet 338 1991 1466 1467
15. M.A. Blome, P. Bjorkman, L. Flamholc, H. Jacobsson, V. Molnegren, and A. Widell Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program J Viral Hepat 18 2010 831 839
16. B.M. Mathers, L. Degenhardt, B. Phillips, L. Wiessing, M. Hickman, and S.A. Strathdee Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review Lancet 372 2008 1733 1745
17. H.E. Harris, M.E. Ramsay, and N.J. Andrews Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure Epidemiol Infect 134 2006 472 477
18. M. Wiese, K. Grungreiff, W. Guthoff, M. Lafrenz, U. Oesen, and H. Porst Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25-year multicenter study J Hepatol 43 2005 590 598
19. E. Kenny-Walsh Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group N Engl J Med 340 1999 1228 1233
20. L. Degenhardt, C. Bucello, B. Mathers, C. Briegleb, H. Ali, and M. Hickman Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies Addiction 106 2011 32 51
21. L.B. Seeff, F.B. Hollinger, H.J. Alter, E.C. Wright, C.M. Cain, and Z.J. Buskell Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study Hepatology 33 2001 455 463
22. L.H. Omland, P. Jepsen, N. Weis, P.B. Christensen, A.L. Laursen, and H. Nielsen Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study J Viral Hepat 17 2010 261 268
23. A. Gibson, D. Randall, and L. Degenhardt The increasing mortality burden of liver disease among opioid dependent people: cohort study Addiction 106 2011 2186 2192
24. L.H. Omland, H. Krarup, P. Jepsen, J. Georgsen, L.H. Harritshoj, and K. Riisom Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study J Hepatol 53 2010 36 42
25. J. Grebely, J.D. Raffa, C. Lai, T. Kerr, B. Fischer, and M. Krajden Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents J Viral Hepat 18 2011 32 41
26. C.M. Chen, Y.H. Yoon, H.Y. Yi, and D.L. Lucas Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis Alcohol Clin Exp Res 31 2007 285 292
27. G.C. Alfsen, L.G. Lyckander, A.W. Lindboe, and H. Svaar Quality control of deaths in hospitals Tidsskr Nor Laegeforen 130 2010 476 479
28. A.G. Mann, M.E. Ramsay, L.J. Brant, M.A. Balogun, A. Costella, and H.E. Harris Diagnoses of, and deaths from, severe liver disease due to hepatitis C in England between 2000 and 2005 estimated using multiple data sources Epidemiol Infect 107 2008 1 6
29. M. Miller, I. Mella, H. Moi, and A. Eskild HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway J Acquir Immune Defic Syndr 33 2003 373 379
30. H. Hagan, E.R. Pouget, J. Des, and C. Lelutiu-Weinberger Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place Am J Epidemiol 168 2008 1099 1109
31. M.C. Clatts, V. Colon-Lopez, L.M. Giang, and L.A. Goldsamt Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection J Urban Health 87 2010 278 291
32. R.J. Garten, S. Lai, J. Zhang, W. Liu, J. Chen, and D. Vlahov Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China Int J Epidemiol 33 2004 182 188
33. O. Dalgard, A. Egeland, R. Ervik, K. Vilimas, K. Skaug, and T.W. Steen Risk factors for hepatitis C among injecting drug users in Oslo Tidsskr Nor Laegeforen 129 2009 101 104